Ultime notizie per Huntsman (NYSE:HUN) Azioni

Huntsman

Huntsman Corp is a us-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. It derives most of its revenue from the Polyurethanes segment which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

BLMN

LYFT

Scopri i 3 titoli top che gli insider stanno acquistando: Lyft, Huntsman e Bloomin&#39; Brands mostrano segnali di fiducia.

Ecco cosa stanno acquistando gli insider: 3 titoli top

Huntsman Corp

HUITONGDA NETWORK U/ADR by HUITONGDA NETWORK CO LTD.

HUANENG PWR INTL by Huaneng Power International, Inc.

Huaneng Power International Inc

HUNT

HUNTER MARITIME ACQ CRP A by Hunter Maritime Acquisition Corp.

Hunter Maritime Acquisition Corp

<p>Wells Fargo  analyst Michael Sison   maintains Huntsman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>) with a Overweight and lowers the price target from $26 to $25.</p>


Price Target

Analyst Ratings

Wells Fargo Maintains Overweight on Huntsman, Lowers Price Target to $25

<p>UBS  analyst Joshua Spector   maintains Huntsman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>) with a Neutral and lowers the price target from $24 to $23.</p>


UBS Maintains Neutral on Huntsman, Lowers Price Target to $23

WIIM

Huntsman shares are trading lower after the company reported worse-than-expected Q3 sales results.

Earnings

Earnings Beats

Earnings Misses

Huntsman Q3 2024 Adj. EPS $0.10 Beats $0.09 Estimate, Sales $1.54B Miss $1.551B Estimate

<p>During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.</p>
<p>Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.</p>
<p>Below are the ratings of the most accurate analysts for three high-yielding stocks in the materials sector.</p>
<h3 class="wp-block-heading"><strong>The Chemours Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CC#NYSE">CC</a>)</strong></h3>
<ul>
<li><strong>Dividend Yield:</strong> 5.46%</li>
<li><strong>BMO Capital </strong>analyst John McNulty maintained an Outperform rating and raised the price target from $30 to $32 on Oct. 7. This analyst has an accuracy rate of 68%.</li>
<li><strong>Barclays </strong>analyst Michael Leithead maintained an Equal-Weight rating and cut the price target from $22 to $21 on Sept. 25. This analyst has an accuracy rate of 77%.</li>
<li><strong>Recent News:</strong> On Wednesday, the company's board declared a quarterly cash dividend of 25 cents per share on the Company&#8217;s common stock for the fourth quarter.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent102424&amp;t=be2bearmibe3na1">latest CC news</a>.  </li>
</ul>
<h3 class="wp-block-heading"><strong>Mercer International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MERC#NASDAQ">MERC</a>)</strong></h3>
<ul>
<li><strong>Dividend Yield:</strong> 4.91%</li>
<li><strong>CIBC </strong>analyst Hamir Patel maintained a Neutral rating and cut the price target from $10 to $8.5 on Aug. 13. This analyst has an accuracy rate of 66%.</li>
<li><strong>RBC Capital </strong>analyst Matthew McKellar maintained a Sector Perform rating and cut the price target from $10 to $8 on Aug. 12. This analyst has an accuracy rate of 67%.</li>
<li><strong>Recent News: </strong>On Wednesday, Mercer International announced the pricing of private add-on offering of senior notes.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent102424&amp;t=be2bearmibe3na1">MERC news.</a> </li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent102424&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="915" height="852" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/24052322/image-228.png" alt="" class="wp-image-611532" style="width:697px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/24052322/image-228.png 915w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/24052322/image-228-300x279.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/24052322/image-228-768x715.png 768w" sizes="(max-width: 915px) 100vw, 915px" /></a></figure></p>
<h3 class="wp-block-heading"><strong>Huntsman Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>)</strong></h3>
<ul>
<li><strong>Dividend Yield: </strong>4.38%</li>
<li><strong>Wells Fargo </strong>analyst Michael Sison maintained an Overweight rating and cut the price target from $28 to $26 on Aug. 7. This analyst has an accuracy rate of 71%.</li>
<li><strong>UBS </strong>analyst Joshua Spector maintained a Neutral rating and slashed the price target from $23 to $22 on Aug. 6. This analyst has an accuracy rate of 62%.</li>
<li><strong>Recent News: </strong>Huntsman will hold a conference call on Tuesday, Nov. 5, to discuss its third quarter financial results.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent102424&amp;t=be2bearmibe3na1">trend in HUN stock</a>.  </li>
</ul>

<p><figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"><br />
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
<p></p></figure></p>
<p><strong>Read More: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/news/earnings/24/10/41508724/tesla-dow-and-3-stocks-to-watch-heading-into-thursday">Tesla, Dow And 3 Stocks To Watch Heading Into Thursday</a></strong></li>
</ul>


MERC

Wall Street's Most Accurate Analysts Spotlight On 3 Materials Stocks Delivering High-Dividend Yields

<p>Across the recent three months, 5 analysts have shared their insights on Huntsman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>), expressing a variety of opinions spanning from bullish to bearish.</p>
<p>The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets, analyzed by analysts, offer insights with an average target of $23.6, a high estimate of $26.00, and a low estimate of $21.00. Observing a downward trend, the current average is 8.53% lower than the prior average price target of $25.80. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1728673252_0.png" alt="price target chart" /></p>
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
<p>The perception of Huntsman by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$24.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$21.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$25.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$26.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$22.00</td>
<td>$23.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Huntsman. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Huntsman compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
<p>Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Huntsman's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/HUN/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Huntsman analyst ratings.</strong></a></p>
<h2>Delving into Huntsman's Background</h2>
<p>Huntsman Corp is a us-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. It derives most of its revenue from the Polyurethanes segment which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States &amp; Canada, Europe, Asia-Pacific, and the Rest of the world.</p>
<h3>Huntsman: A Financial Overview</h3>
<p><strong>Market Capitalization:</strong> Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.</p>
<p><strong>Revenue Growth:</strong> Huntsman's revenue growth over a period of 3 months has faced challenges. As of 30 June, 2024, the company experienced a revenue decline of approximately <strong>-1.38%</strong>. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of <strong>1.4%,</strong> the company may need to address challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>0.7%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Huntsman's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of <strong>0.3%,</strong> the company may encounter challenges in delivering satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> Huntsman's debt-to-equity ratio is below the industry average. With a ratio of <b>0.75</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<h2>How Are Analyst Ratings Determined?</h2>
<p>Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Forecasting The Future: 5 Analyst Projections For Huntsman

<p>RBC Capital  analyst Arun Viswanathan   maintains Huntsman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>) with a Sector Perform and raises the price target from $21 to $24.</p>


RBC Capital Maintains Sector Perform on Huntsman, Raises Price Target to $24

Offerings

Huntsman Prices Its Offering Of $350M Of Senior Notes Due 2034

Huntsman International Files For Offering Of $350M 5.700% Senior Notes Due 2034

<p>Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades.</p>
<p>When insiders purchase shares, it indicates their confidence in the company&#8217;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.</p>
<p>Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.</p>
<h3 class="wp-block-heading"><strong>Lyft</strong></h3>
<ul>
<li><strong>The Trade: Lyft, Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) CEO John David Risher <a href="https://www.benzinga.com/quote/LYFT/analyst-ratings">acquired a total of 51,815 shares</a> at an average price of $9.67. To acquire these shares, it cost around $501,025.</li>
<li><strong>What's Happening:</strong> On Aug. 7, Lyft reported second-quarter adjusted EPS of 24 cents, which beat the analyst consensus estimate of 19 cents.</li>
<li><strong>What Lyft Does:</strong> Lyft is the second-largest ride-sharing service provider in the US and Canada, connecting riders and drivers over the Lyft app.</li>
</ul>
<h3 class="wp-block-heading"><strong>Huntsman</strong></h3>
<ul>
<li><strong>The Trade:</strong> <strong>Huntsman Corporation </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>) Exec VP, GC and Sec David M Stryker acquired a total of 2,500 shares at an average price of $20.11. To acquire these shares, it cost around $50,273.</li>
<li><strong>What's Happening:</strong> On Aug. 5, Huntsman posted in-line quarterly earnings.</li>
<li><strong>What Huntsman Does:</strong> Huntsman Corp is a US-based manufacturer of differentiated organic chemical products.</li>
</ul>
<h3 class="wp-block-heading"><strong>Bloomin&#8217; Brands</strong></h3>
<ul>
<li><strong>The Trade:</strong> <strong>Bloomin&#8217; Brands, Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMN#NASDAQ">BLMN</a>) Director Julie T. Kunkel <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 1,000 shares </a>at an average price of $15.65. To acquire these shares, it cost around $15,650.</li>
<li><strong>What's Happening:</strong> On Aug. 6, Bloomin&#8217; Brands reported second-quarter adjusted EPS of 51 cents, missing the analyst consensus of 58 cents.</li>
<li><strong>What Bloomin&#8217; Brands Does:</strong> Bloomin Brands Inc operates as a casual dining restaurant company.</li>
</ul>
<p><strong>Read Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/news/earnings/24/08/40357992/brinker-international-cisco-and-3-stocks-to-watch-heading-into-wednesday">Brinker International, Cisco And 3 Stocks To Watch Heading Into Wednesday</a></strong></li>
</ul>


Insiders Buying Lyft And 2 Other Stocks

Huntsman Files Debt Securities Shelf

<p>RBC Capital  analyst Arun Viswanathan   maintains Huntsman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>) with a Sector Perform and lowers the price target from $30 to $21.</p>


RBC Capital Maintains Sector Perform on Huntsman, Lowers Price Target to $21

<p>JP Morgan  analyst Jeffrey Zekauskas   maintains Huntsman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>) with a Overweight and lowers the price target from $27 to $25.</p>


JP Morgan Maintains Overweight on Huntsman, Lowers Price Target to $25

<p>Wells Fargo  analyst Michael Sison   maintains Huntsman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>) with a Overweight and lowers the price target from $28 to $26.</p>


Wells Fargo Maintains Overweight on Huntsman, Lowers Price Target to $26

<p>Analysts' ratings for Huntsman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>) over the last quarter vary from bullish to bearish, as provided by 5 analysts.</p>
<p>The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Insights from analysts' 12-month price targets are revealed, presenting an average target of $24.8, a high estimate of $28.00, and a low estimate of $22.00. This current average has decreased by 3.88% from the previous average price target of $25.80. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1722967248_0.png" alt="price target chart" /></p>
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
<p>The perception of Huntsman by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$22.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$28.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$23.00</td>
<td>$26.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$24.00</td>
<td>$26.00</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$27.00</td>
<td>$22.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Huntsman. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Huntsman compared to the broader market.</li>
<li><strong>Price Targets:</strong> Gaining insights, analysts provide estimates for the future value of Huntsman's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Huntsman's market position. Stay informed and make well-informed decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/HUN/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Huntsman analyst ratings.</strong></a></p>
<h2>Get to Know Huntsman Better</h2>
<p>Huntsman Corp is a us-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. It derives most of its revenue from the Polyurethanes segment which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States &amp; Canada, Europe, Asia-Pacific, and the Rest of the world.</p>
<h3>Financial Milestones: Huntsman's Journey</h3>
<p><strong>Market Capitalization:</strong> Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.</p>
<p><strong>Negative Revenue Trend:</strong> Examining Huntsman's financials over 3 months reveals challenges. As of 31 March, 2024, the company experienced a decline of approximately <strong>-8.47%</strong> in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.</p>
<p><strong>Net Margin:</strong> Huntsman's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of <strong>-2.52%,</strong> the company may encounter challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Huntsman's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of <strong>-1.16%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Return on Assets (ROA):</strong> Huntsman's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of <strong>-0.5%,</strong> the company may encounter challenges in delivering satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> Huntsman's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.79</strong>.</p>
<h2>The Significance of Analyst Ratings Explained</h2>
<p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<p>Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Key Takeaways From Huntsman Analyst Ratings

<p>UBS  analyst Joshua Spector   maintains Huntsman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>) with a Neutral and lowers the price target from $23 to $22.</p>


UBS Maintains Neutral on Huntsman, Lowers Price Target to $22

<p>Huntsman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>) reported quarterly earnings of $0.14 per share which met the analyst consensus estimate.  The company reported quarterly sales of $1.574 billion which missed the analyst consensus estimate of $1.612 billion by 2.34 percent.  This is a 1.38 percent decrease over sales of $1.596 billion the same period last year.</p>


Huntsman Q2 2024 Adj. EPS $0.14, Inline, Sales $1.574B Miss $1.612B Estimate

<p>During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a <a href="https://www.benzinga.com/yield-investments">high dividend payout</a>. </p>
<p>Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.</p>
<p>Below are the ratings of the most accurate analysts for three high-yielding stocks in the materials sector.</p>
<h3 class="wp-block-heading"><strong>Dow Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>)</strong></h3>
<ul>
<li><strong>Dividend Yield:</strong> 5.05%</li>
<li><strong>Mizuho </strong>analyst John Roberts maintained a Neutral rating and increased the price target from $55 to $62 on April 26. This analyst has an accuracy rate of 77%.</li>
<li><strong>JP Morgan </strong>analyst Jeffrey Zekauskas upgraded the stock from Neutral to Overweight and boosted the price target from $55 to $61 on April 26. This analyst has an accuracy rate of 70%.</li>
<li><strong>Recent News:</strong> On June 20, , Dow signed an agreement to acquire Circulus, a leading recycler of plastic waste into post-consumer resin.</li>
<li><a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071824&amp;t=be2bearmibe3na1">Benzinga Pro's real-time newsfeed</a> alerted to latest DOW news</li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="685" height="716" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/18052217/Screenshot-2024-07-18-at-2.52.06-PM.png" alt="" class="wp-image-442560" style="width:312px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/18052217/Screenshot-2024-07-18-at-2.52.06-PM.png 685w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/18052217/Screenshot-2024-07-18-at-2.52.06-PM-287x300.png 287w" sizes="(max-width: 685px) 100vw, 685px" /></a></figure></p>
<h3 class="wp-block-heading"><strong>Huntsman Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>)</strong></h3>
<ul>
<li><strong>Dividend Yield:</strong> 4.22%</li>
<li><strong>Wells Fargo </strong>analyst Michael Sison maintained an Overweight rating and cut the price target from $32 to $28 on July 11. This analyst has an accuracy rate of 71%.</li>
<li><strong>JP Morgan </strong>analyst Jeffrey Zekauskasupgraded the stock from Underweight to Overweight and boosted the price target from $22 to $27 on June 7. This analyst has an accuracy rate of 70%.</li>
<li><strong>Recent News:</strong> Huntsman is scheduled to hold a conference call on Tuesday, Aug. 6, 2024, to discuss its second quarter financial results.</li>
<li>Benzinga Pro's charting tool helped identify the <a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071824&amp;t=be2bearmibe3na1">trend in HUN's stock</a>.</li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="693" height="745" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/18052250/Screenshot-2024-07-18-at-2.52.45-PM.png" alt="" class="wp-image-442561" style="width:479px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/18052250/Screenshot-2024-07-18-at-2.52.45-PM.png 693w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/18052250/Screenshot-2024-07-18-at-2.52.45-PM-279x300.png 279w" sizes="(max-width: 693px) 100vw, 693px" /></a></figure></p>
<h3 class="wp-block-heading"><strong>The Scotts Miracle-Gro Company </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>)</h3>
<ul>
<li><strong>Dividend Yield:</strong> 3.93%</li>
<li><strong>JP Morgan </strong>analyst Jeffrey Zekauskasmaintained an Overweight rating and raised the price target from $70 to $85 on April 5. This analyst has an accuracy rate of 70%.</li>
<li><strong>Raymond James </strong>analyst Joseph Altobello downgraded the stock from Strong Buy to Market Perform on March 25. This analyst has an accuracy rate of 70%.</li>
<li><strong>Recent News:</strong> On June 6, ScottsMiracle-Gro said it now sees non-GAAP adjusted EBITDA of $530 million to $540 million versus earlier outlook of $575 million.</li>
<li>Benzinga Pro's earnings calendar was used to monitor <a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071824&amp;t=be2bearmibe3na1">SMG's upcoming earnings</a>.</li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="647" height="740" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/18052412/Screenshot-2024-07-18-at-2.54.05-PM.png" alt="" class="wp-image-442562" style="width:414px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/18052412/Screenshot-2024-07-18-at-2.54.05-PM.png 647w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/18052412/Screenshot-2024-07-18-at-2.54.05-PM-262x300.png 262w" sizes="(max-width: 647px) 100vw, 647px" /></a></figure></p>
<p><strong>Read More: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39814553/jim-cramer-says-dont-sell-match-group-youve-just-got-a-very-very-smart-investor-in-there">Jim Cramer Says Don&#8217;t Sell Match Group: &#8216;You&#8217;ve Just Got A Very, Very Smart Investor In There</a>&#8216;</strong></li>
</ul>
<p><figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"><br />
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
<p></p></figure></p>


Dividends

<p>Wells Fargo  analyst Michael Sison   maintains Huntsman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>) with a Overweight and lowers the price target from $32 to $28.</p>


Wells Fargo Maintains Overweight on Huntsman, Lowers Price Target to $28

<p>Ratings for Huntsman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.</p>
<p>The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $25.0, a high estimate of $27.00, and a low estimate of $23.00. This current average reflects an increase of 2.04% from the previous average price target of $24.50. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1720558821_0.png" alt="price target chart" /></p>
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
<p>The standing of Huntsman among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$23.00</td>
<td>$26.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$24.00</td>
<td>$26.00</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$27.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$26.00</td>
<td>$24.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Huntsman. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Huntsman compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts provide insights into price targets, offering estimates for the future value of Huntsman's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>To gain a panoramic view of Huntsman's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/HUN/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Huntsman analyst ratings.</strong></a></p>
<h2>Get to Know Huntsman Better</h2>
<p>Huntsman Corp is a us-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. It derives most of its revenue from the Polyurethanes segment which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States &amp; Canada, Europe, Asia-Pacific, and the Rest of the world.</p>
<h3>Huntsman's Financial Performance</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Decline in Revenue:</strong> Over the 3 months period, Huntsman faced challenges, resulting in a decline of approximately <strong>-8.47%</strong> in revenue growth as of 31 March, 2024. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.</p>
<p><strong>Net Margin:</strong> Huntsman's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of <strong>-2.52%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Huntsman's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of <strong>-1.16%,</strong> the company may encounter challenges in delivering satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Huntsman's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of <strong>-0.5%,</strong> the company may encounter challenges in delivering satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.79</strong>.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.</p>
<p>Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.</p>
<p>In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


A Glimpse Into The Expert Outlook On Huntsman Through 4 Analysts

Analyst Vincent Andrews from Morgan Stanley maintained a Hold rating on Huntsman (HUN – Research Report) and keeping the price target at $28.00. Vi...

Huntsman Corp: Hold Rating Amid Mixed Performance and Future Uncertainties

Mizuho Securities analyst John Roberts CFA has maintained their neutral stance on HUN stock, giving a Hold rating yesterday. John Roberts CFA has g...

Huntsman Faces Operational Challenges and Economic Headwinds: Hold Rating Maintained by John Roberts CFA

In a report released today, Michael Harrison CFA from Seaport Global maintained a Hold rating on Huntsman (HUN – Research Report). The company's sh...

Seaport Global Remains a Hold on Huntsman (HUN)

Huntsman Corporation (HUN) Q3 2024 Earnings Call Transcript

Huntsman declares $0.25 dividend

Huntsman ( ($HUN) ) has released its Q3 earnings. Here is a breakdown of the information Huntsman presented to its investors. Huntsman Corporation ...

Huntsman Corporation Reports Q3 2024 Financial Results

In a report released today, Aleksey Yefremov from KeyBanc maintained a Hold rating on Huntsman (HUN – Research Report). The company's shares closed...

KeyBanc Sticks to Their Hold Rating for Huntsman (HUN)

Wells Fargo analyst Michael Sison lowered the firm's price target on Huntsman (HUN) to $25 from $26 and keeps an Overweight rating on the shares. T...

Huntsman price target lowered to $25 from $26 at Wells Fargo

RBC Capital analyst Arun Viswanathan maintained a Hold rating on Huntsman (HUN – Research Report) on November 6 and set a price target of $23.00. T...

RBC Capital Remains a Hold on Huntsman (HUN)

Huntsman (HUN – Research Report), the Basic Materials sector company, was revisited by a Wall Street analyst yesterday. Analyst Salvator Tiano from...

Huntsman: Positioned for Resilience and Long-Term Growth Amid Market Challenges

Commodities

Press Releases

Huntsman Inaugurates New Innovation Center in Tienen, Belgium

Huntsman to Discuss Second Quarter 2024 Results on August 6, 2024

Jan Buberl Appointed President of Performance Products Division

Huntsman Announces Third Quarter 2024 Common Dividend

Huntsman Announces Second Quarter 2024 Earnings

Huntsman Prices $350 Million of Senior Notes

Huntsman Selects ISNetworld® for Contractor Management

Huntsman to Discuss Third Quarter 2024 Results on November 5, 2024

Huntsman Announces Third Quarter 2024 Earnings

Huntsman Announces Fourth Quarter 2024 Common Dividend

Arcadium Lithium

Ashland

Avient

Braskem

Balchem

Cabot

Chemours

Element Solutions

H.B. Fuller

Hawkins

Innospec

Kronos Worldwide

Quaker Houghton

Minerals Technologies

NewMarket

Ingevity

Olin

PureCycle Technologies, Inc. - Common stock

PureCycle Technologies

Perimeter Solutions

Stepan

Scotts Miracle-Gro Company (The) Common Stock

Scotts Miracle Gro

Sasol

Sensient Technologies Corporation Common Stock

Comments

Huntsman

Notizie

Ultime notizie per Huntsman (NYSE:HUN) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO